Post-approval studies (Phase 4)WithdrawnNCT01229202What this trial is testingUse of Bevacizumab to Modulate the Outcomes of Trabeculectomy SurgeryWho this might be right forGlaucoma Nova Scotia Health Authority
Not applicableNot Yet RecruitingNCT06983353What this trial is testingGuided Growth Technique Use In Treatment Of Hip Sublaxation In CP ChildernWho this might be right forCerebral Palsy (CP)Guided Growth Mohamed Adel Fathy Abdel aleem 50
Not applicableStudy completedNCT03369145What this trial is testingHigh-fat Overfeeding, Hepatokines and Appetite RegulationWho this might be right forInsulin ResistanceType2 Diabetes MellitusNon-Alcoholic Fatty Liver Disease+1 more Loughborough University 12
Early research (Phase 1)Study completedNCT01233895What this trial is testingStudy of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple MyelomaWho this might be right forMultiple Myeloma Sanofi 26
Not applicableStudy completedNCT00716105What this trial is testingEffect of the Level of Dietary Protein on Infant GrowthWho this might be right forInfant Nutrition Société des Produits Nestlé (SPN) 405
Not applicableUnknownNCT06012331What this trial is testingClinical and Radiographic Evaluation of Revascularization of Immature Anterior Permanent Teeth Using Concentrated Growth Factor (CGF) Versus Blood Clot (BC)Who this might be right forRevascularization Cairo University 50
Not applicableUnknownNCT04724083What this trial is testingInflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease CardiomyopathyWho this might be right forFabry Lysosomal and Rare Disorders Research and Treatment Center, Inc. 50
Not applicableUnknownNCT03824756What this trial is testingAssessing the Effectiveness of Strengthening the Growth Monitoring and Promotional Activities in Rural BangladeshWho this might be right forNutritional Status International Centre for Diarrhoeal Disease Research, Bangladesh 2,000
Testing effectiveness (Phase 2)Ended earlyNCT02753595What this trial is testingStudy of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)Who this might be right forMetastatic Breast Cancer Eisai Inc. 25
Not applicableWithdrawnNCT01632592What this trial is testingAbdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone AnalogueWho this might be right forAbdominal Obesity Massachusetts General Hospital
Not applicableStudy completedNCT04768244What this trial is testingImpact of Maternal COVID-19 Disease on Breast Milk and Infant HealthWho this might be right forCovid19 Institute of Agrochemistry and Food Technology, National Research Council 100
Testing effectiveness (Phase 2)Ended earlyNCT00807365What this trial is testingSix Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the ElderlyWho this might be right forElderly Johns Hopkins University 5
Large-scale testing (Phase 3)Ended earlyNCT02442492What this trial is testingSildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth RestrictionWho this might be right forIntrauterine Growth Restriction (IUGR)Fetal Growth Restriction (FGR) University of British Columbia 21
Testing effectiveness (Phase 2)WithdrawnNCT00570375What this trial is testingThe Role of Erlotinib an Epidermal Growth Factor Receptor (EGFR) Inhibitor in the Treatment of Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndrome University of Cincinnati
Not applicableStudy completedNCT00462475What this trial is testingEffect of 5 Years of GH Replacement on AtherosclerosisWho this might be right forHypopituitarismPituitary TumorsGrowth Hormone Deficiency Federico II University 20
Large-scale testing (Phase 3)UnknownNCT00438867What this trial is testingAngiogenesis in Women With Angina Pectoris Who Are Not Candidates for RevascularizationWho this might be right forAngina Pectoris Cardium Therapeutics 300
Testing effectiveness (Phase 2)Study completedNCT00867334What this trial is testingNew Individualized Therapy Trial for Metastatic Colorectal CancerWho this might be right forColorectal NeoplasmColorectal Cancer Inova Health Care Services 10
Not applicableStudy completedNCT05905939What this trial is testingHER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in RussiaWho this might be right forBreast Cancer AstraZeneca 774
Early research (Phase 1)Ended earlyNCT01748812What this trial is testingCinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)Who this might be right forOsteomalacia National Institute of Dental and Craniofacial Research (NIDCR) 1
Testing effectiveness (Phase 2)Study completedNCT01565083What this trial is testingAssess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 213